On February 7, 2022 GlaxoSmithKline plc reported that it will announce its full year and fourth quarter 2021 results to the London Stock Exchange at 07:00 GMT on Wednesday 9 February 2022 (Press release, GlaxoSmithKline, FEB 7, 2022, View Source [SID1234607791]).

Analysts and investors are invited to participate in a conference call and webcast, including a presentation of the results and a Q&A session. This event will take place on the same day at 14:00 GMT.

To participate, please join the live audio webcast, which can be accessed directly via the website. The presentation will also be available on the website about one hour before the event’s start.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!